These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12074648)

  • 1. Total synthesis of pyridovericin: studies toward the biomimetic synthesis of pyridomacrolidin.
    Baldwin JE; Adlington RM; Conte A; Irlapati NR; Marquez R; Pritchard GJ
    Org Lett; 2002 Jun; 4(13):2125-7. PubMed ID: 12074648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unusual oxidative cyclization: studies towards the biomimetic synthesis of pyridomacrolidin.
    Irlapati NR; Baldwin JE; Adlington RM; Pritchard GJ; Cowley A
    Org Lett; 2003 Jun; 5(13):2351-4. PubMed ID: 12816446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridovericin and pyridomacrolidin: novel metabolites from entomopathogenic fungi, Beauveria bassiana.
    Takahashi S; Kakinuma N; Uchida K; Hashimoto R; Yanagisawa T; Nakagawa A
    J Antibiot (Tokyo); 1998 Jun; 51(6):596-8. PubMed ID: 9711226
    [No Abstract]   [Full Text] [Related]  

  • 4. The structures of pyridovericin and pyridomacrolidin, new metabolites from the entomopathogenic fungus, Beauveria bassiana.
    Takahashi S; Uchida K; Kakinuma N; Hashimoto R; Yanagisawa T; Nakagawa A
    J Antibiot (Tokyo); 1998 Nov; 51(11):1051-4. PubMed ID: 9918400
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitors.
    Boschelli DH; Wu Z; Klutchko SR; Showalter HD; Hamby JM; Lu GH; Major TC; Dahring TK; Batley B; Panek RL; Keiser J; Hartl BG; Kraker AJ; Klohs WD; Roberts BJ; Patmore S; Elliott WL; Steinkampf R; Bradford LA; Hallak H; Doherty AM
    J Med Chem; 1998 Oct; 41(22):4365-77. PubMed ID: 9784112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer-supported synthesis of pyridone-focused libraries as inhibitors of anaplastic lymphoma kinase.
    Zhu T; Yan Z; Chucholowski A; Webb TR; Li R
    J Comb Chem; 2006; 8(3):401-9. PubMed ID: 16677010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-phase synthesis of pyridones and pyridopyrazines as peptidomimetic scaffolds.
    Creighton CJ; Zapf CW; Bu JH; Goodman M
    Org Lett; 1999 Nov; 1(9):1407-9. PubMed ID: 10825988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell permeability as a parameter for lead generation in the protein Tyrosine kinase inhibition field.
    Papageorgiou C; Camenisch G; Borer X
    Bioorg Med Chem Lett; 2001 Jun; 11(12):1549-52. PubMed ID: 11412978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinase.
    Li R; Xue L; Zhu T; Jiang Q; Cui X; Yan Z; McGee D; Wang J; Gantla VR; Pickens JC; McGrath D; Chucholowski A; Morris SW; Webb TR
    J Med Chem; 2006 Feb; 49(3):1006-15. PubMed ID: 16451066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomimetic synthesis of the calcineurin phosphatase inhibitor dibefurin.
    Ellerbrock P; Armanino N; Trauner D
    Angew Chem Int Ed Engl; 2014 Dec; 53(49):13414-8. PubMed ID: 25369982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quasiracemic synthesis: concepts and implementation with a fluorous tagging strategy to make both enantiomers of pyridovericin and mappicine.
    Zhang Q; Rivkin A; Curran DP
    J Am Chem Soc; 2002 May; 124(20):5774-81. PubMed ID: 12010052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic atpenin analogs: Potent mitochondrial inhibitors of mammalian and fungal succinate-ubiquinone oxidoreductase.
    Selby TP; Hughes KA; Rauh JJ; Hanna WS
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1665-8. PubMed ID: 20137945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents.
    Li Q; Chu DT; Claiborne A; Cooper CS; Lee CM; Raye K; Berst KB; Donner P; Wang W; Hasvold L; Fung A; Ma Z; Tufano M; Flamm R; Shen LL; Baranowski J; Nilius A; Alder J; Meulbroek J; Marsh K; Crowell D; Hui Y; Seif L; Melcher LM; Plattner JJ
    J Med Chem; 1996 Aug; 39(16):3070-88. PubMed ID: 8759628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase.
    Selness SR; Boehm TL; Walker JK; Devadas B; Durley RC; Kurumbail R; Shieh H; Xing L; Hepperle M; Rucker PV; Jerome KD; Benson AG; Marrufo LD; Madsen HM; Hitchcock J; Owen TJ; Christie L; Promo MA; Hickory BS; Alvira E; Naing W; Blevis-Bal R; Devraj RV; Messing D; Schindler JF; Hirsch J; Saabye M; Bonar S; Webb E; Anderson G; Monahan JB
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4059-65. PubMed ID: 21640588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and the 5-HT6 receptor antagonistic effect of 3-arylsulfonylamino-5,6-dihydro-6-substituted pyrazolo[3,4]pyridinones for neuropathic pain treatment.
    Devegowda VN; Hong JR; Cho S; Lim EJ; Choo H; Keum G; Rhim H; Nam G
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4696-700. PubMed ID: 23820387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile one-pot synthesis of N-difluoromethyl-2-pyridone derivatives.
    Ando M; Wada T; Sato N
    Org Lett; 2006 Aug; 8(17):3805-8. PubMed ID: 16898822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric synthesis of the (S)-1,1-dioxido-isothiazolidin-3-one phosphotyrosine mimetic via reduction of a homochiral (R)-oxido-isothiazolidin-3-one.
    Combs AP; Glass B; Galya LG; Li M
    Org Lett; 2007 Mar; 9(7):1279-82. PubMed ID: 17338536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitors: Design, synthesis and structure-activity relationship study.
    Loughlin WA; Jenkins ID; Karis ND; Schweiker SS; Healy PC
    Eur J Med Chem; 2016 Mar; 111():1-14. PubMed ID: 26851835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recently discovered EZH2 and EHMT2 (G9a) inhibitors.
    Soumyanarayanan U; Dymock BW
    Future Med Chem; 2016 Sep; 8(13):1635-54. PubMed ID: 27548656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators.
    Liu ZD; Kayyali R; Hider RC; Porter JB; Theobald AE
    J Med Chem; 2002 Jan; 45(3):631-9. PubMed ID: 11806714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.